Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 163
Filter
1.
Australas Psychiatry ; : 10398562241261263, 2024 Jun 14.
Article in English | MEDLINE | ID: mdl-38873835

ABSTRACT

OBJECTIVE: To describe disillusionment amongst the clinical community as a result of repeated ideological and organisational change and to suggest a road map forward. CONCLUSION: Despite knowing that change can be disruptive, it will likely remain a constant and necessary feature of organisational life. Various approaches, including the development of a personal sphere of influence and knowing when to resign, are considered.

2.
Nat Commun ; 15(1): 4857, 2024 Jun 07.
Article in English | MEDLINE | ID: mdl-38849365

ABSTRACT

Reticulocyte-binding protein homologue 5 (RH5), a leading blood-stage Plasmodium falciparum malaria vaccine target, interacts with cysteine-rich protective antigen (CyRPA) and RH5-interacting protein (RIPR) to form an essential heterotrimeric "RCR-complex". We investigate whether RCR-complex vaccination can improve upon RH5 alone. Using monoclonal antibodies (mAbs) we show that parasite growth-inhibitory epitopes on each antigen are surface-exposed on the RCR-complex and that mAb pairs targeting different antigens can function additively or synergistically. However, immunisation of female rats with the RCR-complex fails to outperform RH5 alone due to immuno-dominance of RIPR coupled with inferior potency of anti-RIPR polyclonal IgG. We identify that all growth-inhibitory antibody epitopes of RIPR cluster within the C-terminal EGF-like domains and that a fusion of these domains to CyRPA, called "R78C", combined with RH5, improves the level of in vitro parasite growth inhibition compared to RH5 alone. These preclinical data justify the advancement of the RH5.1 + R78C/Matrix-M™ vaccine candidate to Phase 1 clinical trial.


Subject(s)
Antibodies, Monoclonal , Antibodies, Protozoan , Antigens, Protozoan , Malaria Vaccines , Malaria, Falciparum , Plasmodium falciparum , Protozoan Proteins , Malaria Vaccines/immunology , Malaria Vaccines/administration & dosage , Animals , Plasmodium falciparum/immunology , Protozoan Proteins/immunology , Female , Malaria, Falciparum/prevention & control , Malaria, Falciparum/immunology , Malaria, Falciparum/parasitology , Antigens, Protozoan/immunology , Rats , Antibodies, Protozoan/immunology , Antibodies, Monoclonal/immunology , Humans , Epitopes/immunology , Carrier Proteins/immunology , Carrier Proteins/metabolism
3.
Nat Commun ; 15(1): 5226, 2024 Jun 19.
Article in English | MEDLINE | ID: mdl-38890291

ABSTRACT

IL-33 plays a significant role in inflammation, allergy, and host defence against parasitic helminths. The model gastrointestinal nematode Heligmosomoides polygyrus bakeri secretes the Alarmin Release Inhibitor HpARI2, an effector protein that suppresses protective immune responses and asthma in its host by inhibiting IL-33 signalling. Here we reveal the structure of HpARI2 bound to mouse IL-33. HpARI2 contains three CCP-like domains, and we show that it contacts IL-33 primarily through the second and third of these. A large loop which emerges from CCP3 directly contacts IL-33 and structural comparison shows that this overlaps with the binding site on IL-33 for its receptor, ST2, preventing formation of a signalling complex. Truncations of HpARI2 which lack the large loop from CCP3 are not able to block IL-33-mediated signalling in a cell-based assay and in an in vivo female mouse model of asthma. This shows that direct competition between HpARI2 and ST2 is responsible for suppression of IL-33-dependent responses.


Subject(s)
Asthma , Helminth Proteins , Interleukin-1 Receptor-Like 1 Protein , Interleukin-33 , Nematospiroides dubius , Animals , Interleukin-33/metabolism , Interleukin-33/chemistry , Nematospiroides dubius/immunology , Helminth Proteins/metabolism , Helminth Proteins/chemistry , Helminth Proteins/immunology , Mice , Female , Interleukin-1 Receptor-Like 1 Protein/metabolism , Asthma/immunology , Asthma/metabolism , Humans , Signal Transduction , Strongylida Infections/immunology , Strongylida Infections/parasitology , Strongylida Infections/metabolism , Protein Binding , Disease Models, Animal , Binding Sites , Mice, Inbred BALB C , Mice, Inbred C57BL
4.
Aerosp Med Hum Perform ; 95(6): 313-320, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38790122

ABSTRACT

INTRODUCTION: An Australasian Airline's Alcohol and Other Drug (AOD) Program demonstrates abstinence rates that exceed those of general AOD programs. The reasons for this are unclear. The purpose of this research was to develop a theory as to why this program is successful.METHODS: A qualitative examination following grounded theory methodology was undertaken. AOD program patients and healthcare professionals were interviewed until content saturation was reached. Data analysis followed grounded theory to identify the key concepts associated with the program's success.RESULTS: The core theory that emerged highlighted the pivotal roles of a strong employee-company relationship, shared values, and a safety-focused culture in explicating the program's success. This moves beyond the "carrot and stick" model of motivation, where belonging to this organization and safety consciousness serve as powerful drivers for abstinence. Challenges and barriers highlighted some unique challenges to the program in managing the coronavirus pandemic and the difference in approach to substance use in community spaces versus safety-critical employment.DISCUSSION: This research expands the understanding of this AOD program's success in a safety-critical industry, emphasizing the elements of a working relationship that are beyond positive or negative reinforcement. Future research should work to quantify and test the generalizability of these findings.Nairn J, Bell E, Myers J, Higgins M, Johnston B, Newton-Howes G. A grounded theory exploration of addictions treatment within a commercial airline setting. Aerosp Med Hum Perform. 2024; 95(6):313-320.


Subject(s)
Grounded Theory , Substance-Related Disorders , Humans , Substance-Related Disorders/therapy , Substance-Related Disorders/psychology , Male , Qualitative Research , Adult , Female , COVID-19 , Australia , Middle Aged
5.
Elife ; 122024 Apr 24.
Article in English | MEDLINE | ID: mdl-38655765

ABSTRACT

African trypanosomes replicate within infected mammals where they are exposed to the complement system. This system centres around complement C3, which is present in a soluble form in serum but becomes covalently deposited onto the surfaces of pathogens after proteolytic cleavage to C3b. Membrane-associated C3b triggers different complement-mediated effectors which promote pathogen clearance. To counter complement-mediated clearance, African trypanosomes have a cell surface receptor, ISG65, which binds to C3b and which decreases the rate of trypanosome clearance in an infection model. However, the mechanism by which ISG65 reduces C3b function has not been determined. We reveal through cryogenic electron microscopy that ISG65 has two distinct binding sites for C3b, only one of which is available in C3 and C3d. We show that ISG65 does not block the formation of C3b or the function of the C3 convertase which catalyses the surface deposition of C3b. However, we show that ISG65 forms a specific conjugate with C3b, perhaps acting as a decoy. ISG65 also occludes the binding sites for complement receptors 2 and 3, which may disrupt recruitment of immune cells, including B cells, phagocytes, and granulocytes. This suggests that ISG65 protects trypanosomes by combining multiple approaches to dampen the complement cascade.


Subject(s)
Complement C3b , Complement C3b/metabolism , Humans , Protein Binding , Trypanosoma brucei brucei/immunology , Trypanosoma brucei brucei/metabolism , Protozoan Proteins/metabolism , Protozoan Proteins/immunology , Cryoelectron Microscopy , Binding Sites , Complement C3/metabolism , Complement C3/immunology
6.
Australas Psychiatry ; 32(3): 235-237, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38444074

ABSTRACT

OBJECTIVE: To consider the contribution of non-clinical factors in the rising rate of mental health presentations and explore the associated silence within the psychiatric profession. CONCLUSION: Medicalisation, concept creep and group think, alongside societal demand and expectations, have collectively contributed toward a distorted view of mental health and illness. Equitable service provision has been hindered by the silence of important perspectives.


Subject(s)
Mental Disorders , Psychiatry , Humans , Mental Disorders/therapy , Mental Health Services/organization & administration , Medicalization
7.
Sci Rep ; 14(1): 3843, 2024 02 15.
Article in English | MEDLINE | ID: mdl-38360879

ABSTRACT

Despite Plasmodium ovale curtisi (Poc) and wallikeri (Pow) being important human-infecting malaria parasites that are widespread across Africa and Asia, little is known about their genome diversity. Morphologically identical, Poc and Pow are indistinguishable and commonly misidentified. Recent rises in the incidence of Poc/Pow infections have renewed efforts to address fundamental knowledge gaps in their biology, and to develop diagnostic tools to understand their epidemiological dynamics and malaria burden. A major roadblock has been the incompleteness of available reference assemblies (PocGH01, PowCR01; ~ 33.5 Mbp). Here, we applied multiple sequencing platforms and advanced bioinformatics tools to generate new reference genomes, Poc221 (South Sudan; 36.0 Mbp) and Pow222 (Nigeria; 34.3 Mbp), with improved nuclear genome contiguity (> 4.2 Mbp), annotation and completeness (> 99% Plasmodium spp., single copy orthologs). Subsequent sequencing of 6 Poc and 15 Pow isolates from Africa revealed a total of 22,517 and 43,855 high-quality core genome SNPs, respectively. Genome-wide levels of nucleotide diversity were determined to be 2.98 × 10-4 (Poc) and 3.43 × 10-4 (Pow), comparable to estimates for other Plasmodium species. Overall, the new reference genomes provide a robust foundation for dissecting the biology of Poc/Pow, their population structure and evolution, and will contribute to uncovering the recombination barrier separating these species.


Subject(s)
Malaria , Parasites , Plasmodium ovale , Animals , Humans , Parasites/genetics , Sequence Analysis, DNA , Malaria/parasitology , Nigeria
8.
Infect Immun ; 92(3): e0039523, 2024 Mar 12.
Article in English | MEDLINE | ID: mdl-38294241

ABSTRACT

HpARI is an immunomodulatory protein secreted by the intestinal nematode Heligmosomoides polygyrus bakeri, which binds and blocks IL-33. Here, we find that the H. polygyrus bakeri genome contains three HpARI family members and that these have different effects on IL-33-dependent responses in vitro and in vivo, with HpARI1+2 suppressing and HpARI3 amplifying these responses. All HpARIs have sub-nanomolar affinity for mouse IL-33; however, HpARI3 does not block IL-33-ST2 interactions. Instead, HpARI3 stabilizes IL-33, increasing the half-life of the cytokine and amplifying responses to it in vivo. Together, these data show that H. polygyrus bakeri secretes a family of HpARI proteins with both overlapping and distinct functions, comprising a complex immunomodulatory arsenal of host-targeted proteins.


Subject(s)
Nematospiroides dubius , Strongylida Infections , Mice , Animals , Interleukin-33/genetics , Cytokines , Immunomodulation , Immunity
9.
Australas Psychiatry ; 32(1): 44-46, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38111277

ABSTRACT

OBJECTIVE: The aim is to consider Long COVID not as a new clinical entity but as another example of a disabling, historical phenomenon. CONCLUSIONS: A triad of polymorphic symptomatology, an elusive pathophysiological explanation and a hostile defensiveness has appeared throughout history. The reluctance to consider these contextually may delay early intervention and appropriate patient care.


Subject(s)
COVID-19 , Post-Acute COVID-19 Syndrome , Humans , Emotions , COVID-19 Testing
10.
Nature ; 625(7995): 578-584, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38123677

ABSTRACT

The symptoms of malaria occur during the blood stage of infection, when parasites invade and replicate within human erythrocytes. The PfPCRCR complex1, containing PfRH5 (refs. 2,3), PfCyRPA, PfRIPR, PfCSS and PfPTRAMP, is essential for erythrocyte invasion by the deadliest human malaria parasite, Plasmodium falciparum. Invasion can be prevented by antibodies3-6 or nanobodies1 against each of these conserved proteins, making them the leading blood-stage malaria vaccine candidates. However, little is known about how PfPCRCR functions during invasion. Here we present the structure of the PfRCR complex7,8, containing PfRH5, PfCyRPA and PfRIPR, determined by cryogenic-electron microscopy. We test the hypothesis that PfRH5 opens to insert into the membrane9, instead showing that a rigid, disulfide-locked PfRH5 can mediate efficient erythrocyte invasion. We show, through modelling and an erythrocyte-binding assay, that PfCyRPA-binding antibodies5 neutralize invasion through a steric mechanism. We determine the structure of PfRIPR, showing that it consists of an ordered, multidomain core flexibly linked to an elongated tail. We also show that the elongated tail of PfRIPR, which is the target of growth-neutralizing antibodies6, binds to the PfCSS-PfPTRAMP complex on the parasite membrane. A modular PfRIPR is therefore linked to the merozoite membrane through an elongated tail, and its structured core presents PfCyRPA and PfRH5 to interact with erythrocyte receptors. This provides fresh insight into the molecular mechanism of erythrocyte invasion and opens the way to new approaches in rational vaccine design.


Subject(s)
Erythrocytes , Malaria, Falciparum , Multiprotein Complexes , Parasites , Plasmodium falciparum , Protozoan Proteins , Animals , Humans , Antibodies, Neutralizing/immunology , Antigens, Protozoan/chemistry , Antigens, Protozoan/immunology , Cryoelectron Microscopy , Disulfides/chemistry , Disulfides/metabolism , Erythrocytes/metabolism , Erythrocytes/parasitology , Malaria Vaccines/immunology , Malaria, Falciparum/immunology , Malaria, Falciparum/metabolism , Malaria, Falciparum/parasitology , Malaria, Falciparum/pathology , Merozoites/metabolism , Multiprotein Complexes/chemistry , Multiprotein Complexes/immunology , Multiprotein Complexes/metabolism , Multiprotein Complexes/ultrastructure , Parasites/metabolism , Parasites/pathogenicity , Plasmodium falciparum/metabolism , Plasmodium falciparum/pathogenicity , Protozoan Proteins/chemistry , Protozoan Proteins/immunology , Protozoan Proteins/metabolism , Protozoan Proteins/ultrastructure
11.
PLoS Negl Trop Dis ; 17(10): e0011680, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37862287

ABSTRACT

BACKGROUND: Serum or whole blood collection, processing, transport and storage still present significant challenges in low resource settings where mass surveillance is required to sustain disease elimination. Therefore, in this study, we explored the diagnostic efficacy of dried blood spots (DBS) as a minimally invasive and potentially cost-effective alternative sampling technique to whole blood sampling procedures for subsequent detection of Leishmania donovani antibodies or DNA. METHODOLOGY AND PRINCIPAL FINDINGS: Archived serum, DNA samples from whole blood of visceral leishmaniasis (VL) cases and healthy controls, and DBS from corresponding cases and controls, were used. Both molecular and serological assays were optimized to detect L. donovani antibodies or DNA in DBS elute and results were compared against those obtained with whole blood. Serological assays (both rK28 ELISA and rK39 ELISA) of DBS samples showed sensitivity and specificity of 100% and had excellent agreement with results from whole blood samples (kappa value ranged from 0.98-1). Bland-Altman analysis of OD values from rK28-ELISA with DBS elute and patients' serum showed an excellent agreement (ICC = 0.9) whereas a good agreement (ICC = 0.8) was observed in the case of rK39-ELISA. However, qPCR and RPA of DBS samples had a diminished sensitivity of 76% and 68%, respectively, and poor agreement was observed with the whole blood samples. CONCLUSION: Our results demonstrate that DBS offer excellent diagnostic efficiency for serological assays and represent a viable alternative to whole blood sampling procedures.


Subject(s)
Leishmaniasis, Visceral , Humans , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/epidemiology , Antigens, Protozoan , Diagnostic Techniques and Procedures , Sensitivity and Specificity , Antibodies, Protozoan , DNA , Dried Blood Spot Testing/methods
12.
Elife ; 122023 10 05.
Article in English | MEDLINE | ID: mdl-37796723

ABSTRACT

Basigin is an essential host receptor for invasion of Plasmodium falciparum into human erythrocytes, interacting with parasite surface protein PfRH5. PfRH5 is a leading blood-stage malaria vaccine candidate and a target of growth-inhibitory antibodies. Here, we show that erythrocyte basigin is exclusively found in one of two macromolecular complexes, bound either to plasma membrane Ca2+-ATPase 1/4 (PMCA1/4) or to monocarboxylate transporter 1 (MCT1). PfRH5 binds to each of these complexes with a higher affinity than to isolated basigin ectodomain, making it likely that these are the physiological targets of PfRH5. PMCA-mediated Ca2+ export is not affected by PfRH5, making it unlikely that this is the mechanism underlying changes in calcium flux at the interface between an erythrocyte and the invading parasite. However, our studies rationalise the function of the most effective growth-inhibitory antibodies targeting PfRH5. While these antibodies do not reduce the binding of PfRH5 to monomeric basigin, they do reduce its binding to basigin-PMCA and basigin-MCT complexes. This indicates that the most effective PfRH5-targeting antibodies inhibit growth by sterically blocking the essential interaction of PfRH5 with basigin in its physiological context.


Subject(s)
Malaria, Falciparum , Plasmodium falciparum , Humans , Plasmodium falciparum/physiology , Basigin , Erythrocytes/parasitology , Antibodies, Neutralizing , Malaria, Falciparum/parasitology , Protozoan Proteins/metabolism , Protein Binding , Antigens, Protozoan
13.
Trends Parasitol ; 39(12): 1014-1022, 2023 12.
Article in English | MEDLINE | ID: mdl-37758633

ABSTRACT

African trypanosomes show a remarkable ability to survive as extracellular parasites in the blood and tissue spaces of an infected mammal. Throughout the infection they are exposed to the molecules and cells of the immune system, including complement. In this opinion piece, we review decades-worth of evidence about how complement affects African trypanosomes. We highlight the discovery of a trypanosome receptor for complement C3 and we critically assess three recent studies which attempt to provide a structural and mechanistic view of how this receptor helps trypanosomes to survive in the presence of complement.


Subject(s)
Trypanosoma , Trypanosomiasis, African , Animals , Trypanosomiasis, African/parasitology , Mammals
14.
Mov Disord Clin Pract ; 10(6): 967-973, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37332646

ABSTRACT

Background: Functional neurological disorder (FND) is a disabling condition which has poor prognosis without treatment. This study aimed to evaluate the effectiveness of an outpatient integrated multidisciplinary intervention for the condition. Objectives: This study aimed to assess the outcomes of a pilot integrated multidisciplinary treatment clinic for FND with motor symptoms. Methods: Patients were seen simultaneously by a neurology doctor, a physiotherapist, a clinical psychologist, and sometimes a psychiatrist. The primary endpoint was change in quality of life measured by Short Form-36 (SF-36). Secondary outcomes were change in work and social participation measured by the Work and Social Adjustment Scale (WSAS), ability to participate in full-time or part-time employment, self-rated understanding of FND, and self-rated agreement with the diagnosis of FND. Over the year, 13 patients were recruited to the clinic, and 11 agreed to participate in the outcome study. Results: Statistically significant improvements in quality of life were seen across seven out of eight domains of the SF-36, with improvements in individual domains of between 23 and 39 points (of a possible 100). Mean Work and Social Adjustment Scale score halved from 26 to 13 (worst possible is 40). Of the 12 patients treated, one began to work again after complete unemployment, and two who had been working reduced hours due to disability resumed full time work. No patients had worsened occupational status. Conclusions: This intervention is associated with substantial improvements in quality of life and function, and may be more amenable to delivery at non-specialist centers than other described interventions for FND.

15.
Nat Commun ; 14(1): 3637, 2023 06 19.
Article in English | MEDLINE | ID: mdl-37336887

ABSTRACT

The symptoms of malaria occur during the blood stage of infection, when the parasite replicates within human red blood cells. The human malaria parasite, Plasmodium vivax, selectively invades reticulocytes in a process which requires an interaction between the ectodomain of the human DARC receptor and the Plasmodium vivax Duffy-binding protein, PvDBP. Previous studies have revealed that a small helical peptide from DARC binds to region II of PvDBP (PvDBP-RII). However, it is also known that sulphation of tyrosine residues on DARC affects its binding to PvDBP and these residues were not observed in previous structures. We therefore present the structure of PvDBP-RII bound to sulphated DARC peptide, showing that a sulphate on tyrosine 41 binds to a charged pocket on PvDBP-RII. We use molecular dynamics simulations, affinity measurements and growth-inhibition experiments in parasites to confirm the importance of this interaction. We also reveal the epitope for vaccine-elicited growth-inhibitory antibody DB1. This provides a complete understanding of the binding of PvDBP-RII to DARC and will guide the design of vaccines and therapeutics to target this essential interaction.


Subject(s)
Duffy Blood-Group System , Malaria, Vivax , Plasmodium vivax , Humans , Antigens, Protozoan , Erythrocytes/parasitology , Malaria, Vivax/parasitology , Plasmodium vivax/metabolism , Protozoan Proteins/metabolism , Reticulocytes/metabolism , Tyrosine/metabolism
16.
Biotechnol Prog ; 39(2): e3321, 2023 03.
Article in English | MEDLINE | ID: mdl-36546782

ABSTRACT

The COVID-19 pandemic has placed unprecedented pressure on biopharmaceutical companies to develop efficacious preventative and therapeutic treatments, which is unlikely to abate in the coming years. The importance of fast progress to clinical evaluation for treatments, which tackle unmet medical needs puts strain on traditional product development timelines, which can take years from start to finish. Although previous work has been successful in reducing phase 1 timelines for recombinant antibodies, through utilization of the latest technological advances and acceptance of greater business risk or costs, substantially faster development is likely achievable without increased risk to patients during initial clinical evaluation. To optimize lessons learned from the pandemic and maximize multi-stakeholder (i.e., patients, clinicians, companies, regulatory agencies) benefit, we conducted an industry wide benchmarking survey in September/October 2021. The aims of this survey were to: (i) benchmark current technical practices of key process and product development activities related to manufacturing of therapeutic proteins, (ii) understand the impact of changes implemented in COVID-19 accelerated Ab programs, and whether any such changes can be retained as part of sustainable long-term business practices and (iii) understand whether any accelerative action(s) taken have (negatively) impacted the wider development process. This article provides an in-depth analysis of this data, ultimately highlighting an industry perspective of how biopharmaceutical companies can sustainably adopt new approaches to therapeutic protein development and production.


Subject(s)
Biological Products , COVID-19 , Humans , Drug Industry , Biological Products/therapeutic use , Pandemics/prevention & control , Workflow
17.
Opt Express ; 30(18): 32908-32923, 2022 Aug 29.
Article in English | MEDLINE | ID: mdl-36242343

ABSTRACT

We leverage the attention mechanism to investigate and comprehend the contribution of each input symbol of the input sequence and their hidden representations for predicting the received symbol in the bidirectional recurrent neural network (BRNN)-based nonlinear equalizer. In this paper, we propose an attention-aided novel design of a partial BRNN-based nonlinear equalizer, and evaluate with both LSTM and GRU units in a single-channel DP-64QAM 30Gbaud coherent optical communication systems of 20 × 50 km standard single-mode fiber (SSMF) spans. Our approach maintains the Q-factor performance of the baseline equalizer with a significant complexity reduction of ∼56.16% in the number of real multiplications required to equalize per symbol (RMpS). In comparison of the performance under similar complexity, our approach outperforms the baseline by ∼0.2dB to ∼0.25dB at the optimal transmit power, and ∼0.3dB to ∼0.45dB towards the more nonlinear region.

18.
Nat Commun ; 13(1): 5603, 2022 09 24.
Article in English | MEDLINE | ID: mdl-36153317

ABSTRACT

An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising candidates for inclusion in a transmission-blocking malaria vaccine is the gamete surface protein Pfs48/45, which is essential for development of the parasite in the mosquito midgut. Indeed, antibodies which bind Pfs48/45 can prevent transmission if ingested with the parasite as part of the mosquito bloodmeal. Here we present the structure of full-length Pfs48/45, showing its three domains to form a dynamic, planar, triangular arrangement. We reveal where transmission-blocking and non-blocking antibodies bind on Pfs48/45. Finally, we demonstrate that antibodies which bind across this molecule can be transmission-blocking. These studies will guide the development of future Pfs48/45-based vaccine immunogens.


Subject(s)
Malaria Vaccines , Malaria, Falciparum , Animals , Antibodies, Blocking , Antibodies, Protozoan , Malaria, Falciparum/parasitology , Membrane Proteins , Plasmodium falciparum , Protozoan Proteins/chemistry
19.
J Mol Diagn ; 24(11): 1207-1216, 2022 11.
Article in English | MEDLINE | ID: mdl-36116701

ABSTRACT

Recombinase polymerase amplification (RPA) is an isothermal amplification assay that has been ubiquitously utilized in the detection of infectious agents. Like any nucleic acid amplification technology, primer-template complementarity is critical to RPA reaction success. Mismatches arising in the primer-template complex are known to impact reaction kinetics, invalidate downstream analysis, such as nucleic acid quantification, and result in false negatives if used in a diagnostic capacity. Although the impact of specific primer-template mismatches has been well characterized for techniques such as PCR, characterization remains limited for RPA. Through our study, we systematically characterize the impact of mismatches on the RPA reaction, when located in the 3'-anchor region of the primer-template complex. Our investigation identified that the nucleotides involved, as well as position of each mismatch, influence the size of the impact, with terminal cytosine-thymine and guanine-adenine mismatches being the most detrimental. The presence of some mismatch combinations, such as a penultimate cytosine-cytosine and a terminal cytosine-adenine mismatch pairing, led to complete RPA reaction inhibition. Through the successful characterization of 315 mismatch combinations, researchers can optimize their RPA assay accordingly and seek to implement RPA technology for rapid, in-field genotyping.


Subject(s)
Nucleic Acids , Recombinases , Humans , Recombinases/genetics , DNA Primers , Nucleic Acid Amplification Techniques/methods , Cytosine , Adenine , Sensitivity and Specificity
20.
Sensors (Basel) ; 22(16)2022 Aug 17.
Article in English | MEDLINE | ID: mdl-36015905

ABSTRACT

Power line communication within a lithium-ion battery allows for high fidelity sensor data to be transferred between sensor nodes of each instrumented cell within the battery pack to an external battery management system. In this paper, the changing characteristics of the lithium-ion cell at various states of charge are measured, analysed, and compared to understand their effectiveness on the communication channel of a power line communication system for carrier frequencies of 10 MHz to 6 GHz. Moreover, the use of quadrature amplitude modulation (QAM) is investigated to determine its effectiveness as a state-of-the-art modulation method for the same carrier frequency range. The overall results indicate that certain carrier frequencies and QAM orders may not be suitable for the in situ battery pack power line communication due to changes in battery impedance with certain lithium-ion cell states of charge, which cause an increase in error vector magnitude, bit error ratio, and symbol error ratio. Recommendations and trends on the impact of these changing characteristics based upon empirical results are also presented in this paper.

SELECTION OF CITATIONS
SEARCH DETAIL
...